充分利用有限资源：改善头颈部癌症的结局。
Making the Best of Limited Resources: Improving Outcomes in Head and Neck Cancer.
机构信息
Division of Otorhinolaryngology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Department of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai, India.
出版信息
Am Soc Clin Oncol Educ Book. 2021 Mar;41:1-11. doi: 10.1200/EDBK_320923.
Abstract
The overwhelming majority of head and neck cancers and related deaths occur in low- and middle-income countries, which have challenges related to burden of disease versus access to care. Yet the additional health care burden of the COVID-19 pandemic has also impacted access to care for patients with head and neck cancer in the United States. This article focuses on challenges and innovation in prioritizing head and neck cancer care in Sub-Saharan Africa, the Indian experience of value-added head and neck cancer care in busy and densely populated regions, and strategies to optimize the management of head and neck cancer in the United States during the COVID-19 pandemic.
摘要
绝大多数头颈部癌症和相关死亡发生在低收入和中等收入国家，这些国家面临着疾病负担与获得医疗服务之间的挑战。然而，COVID-19 大流行给美国头颈部癌症患者带来的额外医疗负担也影响了他们获得医疗服务的机会。本文主要关注撒哈拉以南非洲地区头颈部癌症护理的优先事项、在繁忙和人口稠密地区提供增值头颈部癌症护理的印度经验，以及在 COVID-19 大流行期间优化美国头颈部癌症管理的策略。
相似文献
1
Making the Best of Limited Resources: Improving Outcomes in Head and Neck Cancer.充分利用有限资源：改善头颈部癌症的结局。
Am Soc Clin Oncol Educ Book. 2021 Mar;41:1-11. doi: 10.1200/EDBK_320923.
2
Ethical framework for head and neck cancer care impacted by COVID-19.COVID-19 对头颈部癌症护理的伦理框架产生影响。
Head Neck. 2020 Jun;42(6):1214-1217. doi: 10.1002/hed.26193. Epub 2020 Apr 28.
3
Treatment patterns and survival among low-income medicaid patients with head and neck cancer.低收入的医疗补助计划患者的头颈癌治疗模式和生存情况。
JAMA Otolaryngol Head Neck Surg. 2013 May;139(5):489-95. doi: 10.1001/jamaoto.2013.2549.
4
Factors affecting access to head and neck cancer care after a natural disaster: a post-Hurricane Katrina survey.影响自然灾害后头颈部癌症治疗可及性的因素：卡特里娜飓风后的调查。
Head Neck. 2011 Jan;33(1):37-44. doi: 10.1002/hed.21393.
5
COVID-19 pandemic and health care disparities in head and neck cancer: Scanning the horizon.COVID-19 大流行与头颈部癌症的医疗保健差距：扫描地平线。
Head Neck. 2020 Jul;42(7):1555-1559. doi: 10.1002/hed.26345. Epub 2020 Jun 20.
6
Recommendations from the Canadian Association of Head and Neck Surgical Oncology for the Management of Head and Neck Cancers during the COVID-19 pandemic.加拿大头颈部外科肿瘤学会关于 COVID-19 大流行期间头颈部癌症管理的建议。
J Otolaryngol Head Neck Surg. 2020 Jul 29;49(1):53. doi: 10.1186/s40463-020-00448-z.
7
Penn Medicine Head and Neck Cancer Service Line COVID-19 management guidelines.宾夕法尼亚大学医学中心头颈部癌症服务线 COVID-19 管理指南。
Head Neck. 2020 Jul;42(7):1507-1515. doi: 10.1002/hed.26318. Epub 2020 Jun 25.
8
Head and Neck Cancer Patient Population, Management, and Oncologic Outcomes from the COVID-19 Pandemic.头颈部癌症患者人群、管理以及 COVID-19 大流行期间的肿瘤学结局。
Curr Oncol. 2024 Jan 11;31(1):436-446. doi: 10.3390/curroncol31010029.
9
Head and neck oncology during the COVID-19 pandemic: Reconsidering traditional treatment paradigms in light of new surgical and other multilevel risks.COVID-19 大流行期间的头颈部肿瘤学：鉴于新的手术和其他多层次风险，重新考虑传统的治疗模式。
Oral Oncol. 2020 Jun;105:104684. doi: 10.1016/j.oraloncology.2020.104684. Epub 2020 Apr 6.
10
Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009.亚洲头颈部癌放化疗后的颈部管理：2009年亚洲肿瘤学峰会共识声明
Lancet Oncol. 2009 Nov;10(11):1086-92. doi: 10.1016/S1470-2045(09)70266-9.
引用本文的文献
1
Using context-specific evidence to inform resource-stratified cancer guidelines: A call for a new approach.利用特定背景证据为资源分层癌症指南提供信息：呼吁采用新方法。
Cancer. 2025 Jan 1;131(1):e35573. doi: 10.1002/cncr.35573. Epub 2024 Sep 22.
2
Cancer-related pain in head and neck cancer survivors: longitudinal findings from the Head and Neck 5000 clinical cohort.头颈癌幸存者的癌症相关疼痛：来自头颈5000临床队列的纵向研究结果
J Cancer Surviv. 2024 Feb 29. doi: 10.1007/s11764-024-01554-x.
3
Prevalence of locoregional recurrence and survival post-treatment of head and neck cancers in Africa: a systematic review and meta-analysis.非洲头颈癌局部区域复发率及治疗后生存率：一项系统评价与荟萃分析
EClinicalMedicine. 2023 Apr 13;59:101964. doi: 10.1016/j.eclinm.2023.101964. eCollection 2023 May.
4
Integrated proteomics and phosphoproteomics revealed druggable kinases in neoadjuvant chemotherapy resistant tongue cancer.整合蛋白质组学和磷酸化蛋白质组学揭示了新辅助化疗耐药性舌癌中的可成药激酶。
Front Cell Dev Biol. 2022 Oct 28;10:957983. doi: 10.3389/fcell.2022.957983. eCollection 2022.
5
Image-Guided Radiation Therapy for Squamous Cell Cancer of the Head and Neck in a Specialized Peruvian Public Hospital.秘鲁一家专业公立医院对头颈部鳞状细胞癌的图像引导放射治疗
Cureus. 2022 Feb 24;14(2):e22569. doi: 10.7759/cureus.22569. eCollection 2022 Feb.
本文引用的文献
1
Semon Lecture: 'Laryngectomy Practice Based on Personal Research', Royal Society of Medicine, 5 November 2020, London, UK.塞蒙讲座：“基于个人研究的喉切除术实践”，英国伦敦，皇家医学会，2020 年 11 月 5 日。
J Laryngol Otol. 2021 Jul;135(7):E3. doi: 10.1017/S0022215121001511. Epub 2021 Jun 17.
2
Disparities in the Uptake of Telemedicine During the COVID-19 Surge in a Multidisciplinary Head and Neck Cancer Population by Patient Demographic Characteristics and Socioeconomic Status.多学科头颈部癌症患者中，按患者人口统计学特征和社会经济地位划分，在 COVID-19 疫情高峰期远程医疗的应用差异。
JAMA Otolaryngol Head Neck Surg. 2021 Feb 1;147(2):209-211. doi: 10.1001/jamaoto.2020.3052.
3
Explaining Racial Disparities in Surgically Treated Head and Neck Cancer.解释手术治疗的头颈部癌症中的种族差异。
Laryngoscope. 2021 May;131(5):1053-1059. doi: 10.1002/lary.29197. Epub 2020 Oct 27.
4
Intensity-modulated radiation therapy versus three-dimensional conformal radiotherapy in head and neck squamous cell carcinoma: long-term and mature outcomes of a prospective randomized trial.调强放疗与三维适形放疗治疗头颈部鳞癌的前瞻性随机试验：长期和成熟的结果。
Radiat Oncol. 2020 Sep 16;15(1):218. doi: 10.1186/s13014-020-01666-5.
5
Head and neck surgery recommendations during the COVID-19 pandemic.2019冠状病毒病大流行期间的头颈外科手术建议。
Lancet Oncol. 2020 Sep;21(9):e416. doi: 10.1016/S1470-2045(20)30440-X.
6
Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial.低剂量口服节拍化疗与静脉注射顺铂治疗复发性、转移性、不可手术的头颈部鳞癌患者的疗效比较：一项开放标签、平行组、非劣效性、随机、3 期临床试验。
Lancet Glob Health. 2020 Sep;8(9):e1213-e1222. doi: 10.1016/S2214-109X(20)30275-8.
7
Development and validation of a Surgical Prioritization and Ranking Tool and Navigation Aid for Head and Neck Cancer (SPARTAN-HN) in a scarce resource setting: Response to the COVID-19 pandemic.在资源匮乏环境下开发并验证头颈部癌症手术优先级和排序工具及导航辅助系统（SPARTAN-HN）：对 COVID-19 大流行的应对。
Cancer. 2020 Nov 15;126(22):4895-4904. doi: 10.1002/cncr.33114. Epub 2020 Aug 11.
8
Cancer Statistics, 2020: Report From National Cancer Registry Programme, India.《2020年癌症统计数据：来自印度国家癌症登记计划的报告》
JCO Glob Oncol. 2020 Jul;6:1063-1075. doi: 10.1200/GO.20.00122.
9
Is AJCC/UICC Staging Still Appropriate for Head and Neck Cancers in Developing Countries?美国癌症联合委员会/国际抗癌联盟（AJCC/UICC）分期系统对发展中国家的头颈癌患者是否仍然适用？
OTO Open. 2020 Jul 6;4(3):2473974X20938313. doi: 10.1177/2473974X20938313. eCollection 2020 Jul-Sep.
10
The 3 Bs of cancer care amid the COVID-19 pandemic crisis: "Be safe, be smart, be kind"-A multidisciplinary approach increasing the use of radiation and embracing telemedicine for head and neck cancer.在 COVID-19 大流行危机中癌症护理的 3B：“安全、明智、善良”-一种增加头颈部癌症放射治疗应用并采用远程医疗的多学科方法。
Cancer. 2020 Sep 15;126(18):4092-4104. doi: 10.1002/cncr.33031. Epub 2020 Jul 8.
Zotero 插件